Top Markets
#1 TENDIES TENDIES +83.50%
#2 Akedo Akedo +81.98%
#3 Verus Coin Verus Coin +43.84%
#4 Threshold Network Threshold Network +43.77%
#5 MultiversX MultiversX +34.16%
#6 Mubarak Mubarak +31.37%
#7 Cash Cat Cash Cat +25.34%
#8 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#9 Bitway Bitway +16.42%
#10 OSK OSK +16.18%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
Atrys Health, S.A. Atrys Health, S.A.

Atrys Health, S.A.

ATRY
Rank in Stocks #17814
Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in... Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in Madrid, Spain, specializes in providing a range of diagnostic services and medical treatments. Its diagnostic portfolio encompasses areas like pathology, hematology, molecular pathology, and genetics, supplemented by offerings such as diagnostic second opinions, a comprehensive test directory, and support for clinical trials and research & development. The company effectively utilizes telemedicine to deliver its expertise in medical specialties including radiology, cardiology, ophthalmology, and dermatology. Furthermore, Atrys Health administers radiotherapy and is engaged in the development of innovative therapeutic approaches and diagnostic instruments. The organization operated as Althia Health, S.L. before rebranding to Atrys Health, S.A. in May 2016.
Share Price
$2.97
Market Cap
$225.13M
Change (1 day)
-0.99%
Change (1 year)
-9.64%
Country
ES
Trade Atrys Health, S.A. (ATRY)

Category

Healthcare
P/E ratio for Atrys Health, S.A. (ATRY)
P/E ratio as of 2026 TTM: 0
According to Atrys Health, S.A. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Atrys Health, S.A. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 31.44 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 36.85 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -17.59 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 -23.32 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.